<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bernardazzi C</submitter><funding>Coordenação de Aperfeicoamento de Pessoal de Nível Superior</funding><funding>National Council for Scientific and Technological Development</funding><funding>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</funding><pagination>4616</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9099551</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(9)</volume><pubmed_abstract>&lt;b>Background:&lt;/b> Given the role of the P2X7 receptor (P2X7R) in inflammatory bowel diseases (IBD), we investigated its role in the development and progression of colitis-associated colorectal cancer (CA-CRC). &lt;b>Methods:&lt;/b> CA-CRC was induced in P2X7R&lt;sup>+/+&lt;/sup> and P2X7R&lt;sup>-/-&lt;/sup> mice with azoxymethane (AOM) combined with dextran sodium sulfate (DSS). In a therapeutic protocol, P2X7R&lt;sup>+/+&lt;/sup> mice were treated with a P2X7R-selective inhibitor (A740003). Mice were evaluated with follow-up video endoscopy with endoluminal ultrasound biomicroscopy. Colon tissue was analyzed for histological changes, densities of immune cells, expression of transcription factors, cytokines, genes, DNA methylation, and microbiome composition of fecal samples by sequencing for 16S rRNA. &lt;b>Resul</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome.</pubmed_title><pmcid>PMC9099551</pmcid><funding_grant_id>E26/202.781/2017</funding_grant_id><funding_grant_id>Finance Code 001</funding_grant_id><funding_grant_id>E26/210.886/2014</funding_grant_id><funding_grant_id>306634/2019-8</funding_grant_id><funding_grant_id>E-26/010.001279/2015</funding_grant_id><funding_grant_id>E-26/202.774/2018</funding_grant_id><pubmed_authors>Castelo-Branco MTL</pubmed_authors><pubmed_authors>Ribeiro BE</pubmed_authors><pubmed_authors>Bernardazzi C</pubmed_authors><pubmed_authors>Coutinho-Silva R</pubmed_authors><pubmed_authors>Rosas SLB</pubmed_authors><pubmed_authors>Santana PT</pubmed_authors><pubmed_authors>de Souza HSP</pubmed_authors><pubmed_authors>Leal C</pubmed_authors><pubmed_authors>Pego B</pubmed_authors><pubmed_authors>Machado JC</pubmed_authors><pubmed_authors>Thompson F</pubmed_authors></additional><is_claimable>false</is_claimable><name>The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome.</name><description>&lt;b>Background:&lt;/b> Given the role of the P2X7 receptor (P2X7R) in inflammatory bowel diseases (IBD), we investigated its role in the development and progression of colitis-associated colorectal cancer (CA-CRC). &lt;b>Methods:&lt;/b> CA-CRC was induced in P2X7R&lt;sup>+/+&lt;/sup> and P2X7R&lt;sup>-/-&lt;/sup> mice with azoxymethane (AOM) combined with dextran sodium sulfate (DSS). In a therapeutic protocol, P2X7R&lt;sup>+/+&lt;/sup> mice were treated with a P2X7R-selective inhibitor (A740003). Mice were evaluated with follow-up video endoscopy with endoluminal ultrasound biomicroscopy. Colon tissue was analyzed for histological changes, densities of immune cells, expression of transcription factors, cytokines, genes, DNA methylation, and microbiome composition of fecal samples by sequencing for 16S rRNA. &lt;b>Resul</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-08-12T03:04:39.067Z</modification><creation>2025-02-19T00:55:41.337Z</creation></dates><accession>S-EPMC9099551</accession><cross_references><pubmed>35563010</pubmed><doi>10.3390/ijms23094616</doi></cross_references></HashMap>